Dengue virus and malaria concurrent infection among febrile subjects within Ilorin metropolis, Nigeria

Autor: Kolawole, OM, Seriki, AA, Irekeola, AA, Bello, KE, Adeyemi, OO

Dengue is a mosquito-borne disease of public health importance. It is caused by four serotypes of Dengue virus (i.e, DENV-1, -2, -3, and -4). As a result of practices that are conducive for mosquito breading, its vector is widespread in Nigeria and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::02a4f696cf9b98a00b8a7a059b3c42fc
https://eprints.whiterose.ac.uk/117352/1/adeyemi_dengue.pdf

The Right to Health as a Claim on Dignity: Implications for State Accountability in Nigeria

Autor: Kolawole, Omowamiwa

This thesis argues that dignity is central to the realisation of the right to health in Nigeria and shapes the relationship of the Nigerian State with its people. The thesis posits that a contextual understanding of the nature of human dignity in Nig

Externí odkaz: http://hdl.handle.net/11427/35748

Recent advances in modified chitosan-based drug delivery systems for transmucosal applications: A comprehensive review.

Autor: Abu Elella MH; School of Pharmacy, University of Reading, Reading RG6 6AD, United Kingdom; Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt. Electronic address: m.h.e.abuelella@reading.ac.uk., Kolawole OM; Department of Pharmaceutics and Pharmaceutical Technology, University of Lagos, Lagos, Nigeria.

Publikováno v: International journal of biological macromolecules [Int J Biol Macromol] 2024 Oct; Vol. 277 (Pt 4), pp. 134531. Date of Electronic Publication: 2024 Aug 06.

Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses.

Autor: Oladipo EK; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Laboratory of Molecular Biology, Immunology and Bioinformatics, Department of Microbiology, Adeleke University, Ede, Osun State, Nigeria., Oyelakin OD; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Aiyelabegan AO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Olajide EO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Molecular Biology and Biotechnology Department, Nigeria Institute of Medical Research, Lagos, Nigeria., Olatayo VO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Owolabi KP; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Shittu YB; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Olugbodi RO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Ajala HA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Rukayat RA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Olayiwola DO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Irewolede BA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Jimah EM; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Oloke JK; Department of Natural Sciences, Precious Cornerstone University, Ibadan, Oyo State, Nigeria., Ojo TO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Ajani OF; African Centre for Disease Control HQ, Addis Ababa, Ethiopia., Iwalokun BA; Molecular Biology and Biotechnology Department, Nigeria Institute of Medical Research, Lagos, Nigeria., Kolawole OM; Department of Microbiology, University of Ilorin, Ilorin, Kwara State, Nigeria., Ariyo OE; Department of Medicine, Infectious Disease and Tropical Medicine Unit, Federal Teaching Hospital, Ido Ekiti, Ekiti State, Nigeria., Adediran DA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria., Olufemi SE; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria., Onyeaka H; School of Chemical Engineering, University of Birmingham, Birmingham, UK.

Publikováno v: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Aug; Vol. 12 (8), pp. e1360.

Characterization and risk assessment of polycyclic aromatic hydrocarbons from the emission of different power generator.

Autor: Adesina OA; Department of Chemical and Petroleum Engineering, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria., Kolawole OM; Department of Food Science Federal Polytechnic, Ado-Ekiti, Ekiti State, Nigeria., Lala MA; Department of Chemical and Petroleum Engineering, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria., Omofoyewa MG; Department of Chemical and Petroleum Engineering, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria., Igbafe AI; Department of Chemical and Petroleum Engineering, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.

Publikováno v: Heliyon [Heliyon] 2024 May 21; Vol. 10 (11), pp. e31687. Date of Electronic Publication: 2024 May 21 (Print Publication: 2024).